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Abstract 
 
Background: Hypertension is present in 30% of the adult U.S. population and is a major 
contributor to cardiovascular disease.  The established office-based approach yields only 
50% blood pressure control rates and low levels of patient engagement. Available home 
technology now provides accurate, reliable data that can be transmitted directly to the 
electronic medical record. 
Methods: We evaluated blood pressure control in 156 patients with uncontrolled 
hypertension enrolled into a home-based digital medicine blood pressure program and 
compared them to 400 patients (matched to age, gender, body mass index and blood 
pressure) in a usual care group after 90 days. Digital medicine patients completed 
questionnaires on-line, were asked to submit ≥1 blood pressure reading/week, and 
received medication management and lifestyle recommendations via a clinical 
pharmacist and a health coach.  Blood pressure units were commercially available, that 
transmitted data directly to the electronic medical record.  
Results: Digital Medicine patients averaged 4.2 blood pressure readings per week.  At 
90-days 71% of digital medicine versus 31% of usual care patients had achieved target 
blood pressure control. Mean drop in systolic/diastolic blood pressure was 14/5 mmHg 
in digital medicine versus 4/2 mmHg in usual care (p<0.001).  Excess sodium 
consumption decreased from 32% to 8% in the digital medicine group (p=0.004).  Mean 
patient activation increased from 41.9 to 44.1 (p=0.008) and the percentage of patients 
with low patient activation decreased from 15% to 6% (p=0.03) in the digital medicine 
group. 
Conclusion: A digital hypertension program is feasible and associated with significant 
improvement in blood pressure control rates and lifestyle change.  Utilization of a virtual 
health intervention using connected devices improves patient activation and is well 
accepted by patients. 
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Introduction 
Hypertension is a major contributor to cardiovascular disease and is the leading risk 
factor contributing to the global disease burden, representing approximately ten 
percent of all global healthcare spending. (1,2) Despite effective pharmacologic and 
non-pharmacologic therapies, the current office-based approach produces suboptimal 
results in which approximately half of the 80 million United States (US) adults with 
hypertension remain uncontrolled. (3,4) Several factors account for these poor 
outcomes, including the use of suboptimal doses of medications, lack of patient 
engagement, and limited resources and time to educate and provide lifestyle 
recommendations. (5) Although many types of interventions have been tested, recent 
systematic reviews conclude that what is needed is a reorganization of clinical practice 
and empowerment of nonphysician practitioners to adjust anti-hypertensive therapy.(6)  
 
Home blood pressure monitoring addresses several limitations of traditional office-
based care, including a larger sample of biologic data, reducing misclassification due to 
white-coat or masked hypertension, and an ability to take more timely action and 
course correct therapy.(3) Current technology is accurate and easy to use, and home-
based blood pressure measurements better predicts cardiovascular risk than office 
measurements. (7) Moreover, home blood pressure monitoring avoids the 
inconvenience of an office-based encounter and in and of itself, enhances patient 
engagement, which independently plays an important role in medication and lifestyle 
adherence. (7-10)   
 
We sought to evaluate the effectiveness of a remote, home-based telemonitoring 
program in a clinical setting using commercially available technologies, on blood 
pressure control and patient engagement in patients with uncontrolled hypertension. 
 
Methods 
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We identified adult patients with the diagnoses of hypertension at the Ochsner Health 
System who had elevated blood pressure (systolic pressure > 140 mmHg or diastolic 
pressure > 90 mmHg) at each of the 3 most recent physician visits within the previous 
18 months.  Patients meeting these requirements were enrolled by their physician 
during an office encounter or through an offer letter by their physician.  Patients were 
required to possess a smartphone as well as purchase a wireless blood pressure unit 
from a list of preselected vendors based on the smartphone’s operating system (OS). For 
Android phones the vendor option was Withings, for Apple iPhones, the options 
included Withings, and iHealth.  The electronic medical record (Epic Systems©) provided 
a direct interface to Withings regardless of OS as well as a secure interface to Apple 
HealthKit, thus providing an array of device options for units that interfaced with 
HealthKit.  Patients also were required to have an active account in the patient portal 
(Epic MyChart©), which was free; if patients did not have an active account, they were 
given the opportunity to sign up for one. 
Program details, questionnaires, and electronic consent to participate took place on-line 
through MyChart. Questionnaires assessed factors related to hypertension and chronic 
disease management, including dietary sodium and alcohol consumption, depression, 
medication adherence, patient activation, physical activity, health literacy, social 
circumstances (i.e. medication affordability, number living in home, etc.) and screening 
for obstructive sleep apnea. (5) Additional clinical data was obtained from the electronic 
medical record, including serum sodium, potassium, and creatinine, estimated 
glomerular filtration rate (eGFR), thyroid function tests, and body mass index (BMI).  
This data was used to create a patient phenotype that assisted in the design of the 
intervention process. 
Patients were asked to take no less than one blood pressure reading per week but were 
encouraged to take 3-4 per week.  If the care team had not received a blood pressure 
reading for 8 days, patients would receive an automated text, alerting them that a blood 
pressure measurement was needed.  Blood pressure units were purchased and initial 
training and setup was provided at the Ochsner O Bar, a patient-facing service that 
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provides information, training and tech support for patients interested in apps, 
wearables and connected home devices. (11) 
A second group of patients who met eligibility criteria but whose physician was not 
participating in the program were followed.  Of these, 400 patients were matched to the 
digital medicine group according to age, gender, BMI, and initial blood pressure, and 
were followed as a usual care group over time. Usual care patients received routine care 
through their primary care physician and averaged 0.8 visits over 90 days.  
 
Doctoral pharmacists and health coaches participated in the intervention that included 
education, drug management and lifestyle recommendations as per hypertension 
guidelines. (12,13) Each pharmacist received training in hypertension management as 
well as use of the custom tools within the electronic medical record created to facilitate 
optimal management. Pharmacists and health coaches were also educated regarding 
the importance of patient engagement and methods used to enhance engagement and 
lifestyle change. 
We developed a health capability score composed of four patient domain factors 
impacting chronic disease outcomes: social isolation, capabilities to process and 
understand health information (health literacy), engagement in their disease process 
(patient activation), and economic barriers impacting treatment plans (medication 
affordability).  One point was assigned to any deficiency in each component with a 
higher score indicating declining health capability.   
 
Interventions 
Pharmacists contacted patients by phone and discussed the screening results as well as 
treatment options for improving blood pressure control. Patients were encouraged to 
be an active participant in their hypertension management and worked with the 
pharmacist to co-create the treatment plan by choosing among various lifestyle and 
medication options.  Patients were also directed to a dedicated hypertension website 
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that offered further educational and lifestyle materials including custom videos and 
downloadable handouts.   
Those who screened positive for depression or obstructive sleep apnea were referred to 
their physician or to the appropriate specialist based on physician preference.  Patients 
who screened positive for excess dietary sodium received focused education on the 
importance of reducing dietary sodium and were additionally asked if other individuals 
were involved in the purchase or preparation of their meals. If affirmative, and following 
patient consent, these individuals were contacted by automated email at the behest of 
the patient, and provided video education and other educational resources on the 
importance of choosing low sodium foods when purchasing or preparing meals. 
Patients with medication affordability issues were as much as possible, switched to 
generics or less expensive combination agents, and when appropriate and feasible, 
enrolled in medication assistance programs.  Those with medication adherence issues 
were provided educational materials, pill reminder apps and resources, as well as a 
simplified medication regimen when possible. 
Patients received monthly reports (Figure 1) detailing their progress along with lifestyle 
tips based on their screening phenotype.  Physicians also received monthly reports on 
their patient’s progress.  Incoming blood pressure data was analyzed via internally 
developed algorithms as to its validity and directional change, and alerts were 
established to highlight which patients needed what intervention and when.  
 
Outcomes 
The primary outcome was the proportion of patients with controlled blood pressure, 
defined as a blood pressure < 140/90 mmHg or < 130/80 if diabetes or chronic kidney 
disease was present, at 90 days.  Other outcomes included change in systolic blood 
pressure and diastolic blood pressure at 90 days, and improvement in patient 
engagement using patient activation measure. (8) 
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Statistical Analysis 
Statistical analysis was performed using SPSS version 16.0 (SPSS Inc., Chicago, IL). 
Results are expressed as mean ± standard deviation (SD), or as n (%) where appropriate.  
Analysis of differences between groups was performed using Student’s t-test for 
continuous variables, Chi-square test for categorical variables and ANOVA for 
differences among frequencies for several groups. Logistic regression was used in the 
health capability analysis in which the response variable was blood pressure control at 
90 days. In all analysis, two-sided P<0.05 was considered significant. 
 
Results 
Of the initial 195 patients who were offered the digital medicine program, 156 accepted 
enrollment and 39 declined participation. The baseline characteristics of the digital 
medicine (n=156) and usual care groups (n=400) are outlined in Table 1.  There were no 
significant differences in age, gender, BMI, baseline blood pressure measures, and other 
characteristics. 
Table 2 highlights additional baseline data in the digital medicine group.  Of note, the 
high prevalence of lifestyle contributing factors, including physical inactivity and high 
dietary sodium. 
Table 3 describes the changes in blood pressure metrics and other health metrics at 90 
days in the digital medicine (a) and usual care (b) groups.  Blood pressure including 
systolic, diastolic, mean arterial pressure (MAP) and pulse pressure improved 
significantly in both groups (p<0.001).  At 90 days, 71% of patients in the digital 
medicine group achieved blood pressure control compared to 31% of the usual care 
group (p<0.001).  Over the 90-day period, the usual care group had an average of 0.8 ± 
0.4 blood pressure recordings noted in the electronic medical record compared to 55 ± 
16 recordings (averaging 4.2/week) in the digital medicine group (p<0.0001). 
Table 4 describes the patient characteristics of digital medicine patients who achieved 
90-day blood pressure control (n = 111; 71%) compared to those who had not achieved 
blood pressure control (n=45; 29%).  Those patients who had not achieved 90-day blood 
pressure control had higher entry systolic and diastolic blood pressures, were more 
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likely to suffer depression, have diabetes, be unable to afford their medication, and take 
more anti-hypertensive medications.    
Other characteristics of interest in the poorly controlled group, but of borderline 
statistical significance, were trends towards a higher prevalence of social isolation, and 
poor health literacy. The mean health capability score was twofold higher in the poorly 
controlled group than in those patients achieving blood pressure control (0.80 ± 0.82 
versus 0.39 ± 0.64; p=0.002) and more than half of the poorly controlled group exhibited 
some impairment in health capability. 
Table 5 describes the likelihood of achieving blood pressure control based on the health 
capability score.  Relative to a health capability score of zero, the odds ratio of achieving 
blood pressure control with a health capability score of 1 was 0.58 (CI 0.26 – 1.3; 
p=0.20), and 0.17 (CI 0.06 – 0.50; p=0.001) when the health capability score was ≥2. 
 
 
Discussion 
There are two important findings from this investigation.  First, it is feasible to 
significantly improve hypertension control as well as enhance patient activation using a 
digital health monitoring and intervention program.  Second, patient-oriented factors 
comprising an individual’s health capability have a significant clinical impact in achieving 
blood pressure control. 
 
Management of chronic disease is a multidimensional process that is influenced by the 
three parties governing care: the clinician, the patient, and the health delivery system. 
(5) The most common chronic disease is hypertension, with a prevalence of 30% of the 
adult US population, yet only 50% of hypertension patients achieve blood pressure 
control. (4,14) Poor blood pressure control increases morbidity and mortality, and due 
to only modest national control rates, hypertension-related deaths have increased 23% 
in the last decade compared to a 21% reduction in all other causes of death combined. 
(15) Failure in controlling blood pressure has been linked to therapeutic inertia, present 
in up to 87% of patients with poorly controlled hypertension. (5,16) We have shown that 
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redesigning care delivery using a digital health program can substantially improve blood 
pressure control, with 71% of previously uncontrolled hypertension patients achieving 
blood pressure control within 90 days compared to only 31% of usual care patients.  
These improvements in blood pressure control are also timely, as delays in controlling 
elevated blood pressure have been demonstrated to impact outcomes; delays of greater 
than 1.4 months before medication intensification and delays greater than 2.7 months 
before blood pressure follow-up after medication intensification are associated with 
increases in cardiovascular events and all-cause mortality. (17)  
 
It is noteworthy that the intervention impacted all three domains of care, and included a 
focused characterization and intervention in the patient domain.  We report that patient 
activation was significantly improved by the intervention, with a reduction of those who 
were classified as poorly activated by 60% (p=0.03).  This was likely due to several 
factors, including self-measurement of blood pressure, co-creation of treatment goals, 
and regular feedback in the manner of monthly reports, intermittent texts and phone 
calls.  In patients with chronic disease, increasing patient activation can improve 
medication adherence, decrease adverse outcomes, and reduce total healthcare costs. 
(8,18,19) It is notable that the intervention included education and resources towards 
lifestyle changes that was delivered not only to the patient, but also to members of the 
patient’s social network who had influence over diet, resulting in a significant reduction 
in dietary sodium consumption. (20)  
Although the digital medicine program achieved quality improvements over usual care, 
29% of patients failed to reach target blood pressure goals by 90 days.  These patients 
had higher entry blood pressure and were more likely diabetic, but also exhibited a 
threefold higher prevalence of depressive symptoms.  Additionally, they noted a greater 
difficulty in paying for their medication and trended towards more social isolation and 
lower health literacy.  Taken together the health capability score provided a measure of 
the likelihood of achieving blood pressure control as viewed from the patient domain.  
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Compared to patients with a health capability score of 0, those with a score of ≥2 had a 
likelihood of only 17% of achieving blood pressure control at 90 days (p=0.001). 
 
Limitations 
First, this was a single-center study and patients were not prospectively randomized into 
intervention (digital medicine) and usual care groups.  Second, only patients who 
possessed a smartphone were eligible to enroll, which raises issues regarding education, 
socioeconomic, and motivational biases.  However, the mean age of our population was 
68 years and on screening, 23% lacked common technology skills, suggesting that our 
cohort was not biased towards a younger, more tech savvy population. 
 
Conclusion 
A digital health program in the clinical care setting can be an effective mechanism of 
delivering hypertension management, outperforming traditional office-based care.  The 
program was well accepted by patients and has the additional value of improving 
patient engagement.  Factors in the patient domain, such as health literacy, patient 
activation, social isolation, and medication affordability play a significant role in disease 
control and should be considered in population health management strategies. 
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Figure Legend  
 
Figure 1 - Monthly patient report in the digital medicine program. 
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Table 1 
 
Baseline characteristics in the Usual Care and Digital Medicine groups. 
 
 
 
 
Usual Care 
(n=400) 
Digital 
Medicine 
(n=156) 
p-value 
Age (years) 68 ± 10 68 ± 10 NS 
Gender (% female) 54% 54% NS 
Body mass index (kg/m2) 31.7 ±7.4 30.8 ± 6.3 NS 
% Black 23% 22% NS 
% Diabetic 36% 29% NS 
Baseline systolic pressure 
(mmHg) 
147 ±5 147 ±14 NS 
Baseline diastolic pressure 
(mmHg) 
81 ± 8 81 ± 12 NS 
Mean arterial pressure (mmHg) 103 ± 6 103 ± 12 NS 
Pulse pressure (mmHg) 65 ± 9 66 ± 16 NS 
Creatinine (mg/dl) 1.0 ±0.5 1.1 ± 0.5 NS 
eGFR (ml/min/1.73m2) 55.2 ± 9.9 56.5 ± 8.9 NS 
TSH (ulU/ml) 2.0 ± 1.0 1.9 ± 1.5 NS 
% Obese 54% 52% NS 
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Table 2 
Additional baseline characteristics of the Digital Medicine group (n=156). 
 
 
Physically inactive (%) 76% 
Lives alone (%) 17% 
Depression (%) 17% 
Poor health literacy (%) 6% 
Medication affordability issue (%) 12% 
Obstructive sleep apnea screen + (%) 22% 
High dietary sodium intake (%) 32% 
Low medication adherence (%) 17% 
Low patient activation (%) 15% 
Number of antihypertensive meds 3.7 ± 1.5 
Poor technology skills (%) 23% 
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Table 3 
 
(a) Changes in blood pressure and health metrics in the Digital Medicine group at 90 
days (n=156). 
 
 Baseline 90-days p-value 
Systolic blood pressure 
(mmHg) 
147 ± 19 133 ± 12 <0.001 
Diastolic blood pressure 
(mmHg) 
81 ± 12 76 ± 9 <0.001 
Mean arterial pressure (mmHg) 103 ± 12 95 ± 9 <0.001 
Pulse pressure (mmHg) 66 ± 16 57 ± 11 <0.001 
High dietary sodium intake (%) 32% 8% 0.004 
Patient activation score 41.9 ± 6.6 44.1 ± 6.7 0.008 
Low patient activation (%) 15% 6% 0.03 
 
 
 
(b) Changes in BP metrics in the Usual Care group at 90 days (n=400). 
 
 Baseline 90-days p-value 
Systolic blood pressure 
(mmHg) 
147 ± 5 143 ± 14 <0.001 
Diastolic blood pressure 
(mmHg) 
81 ± 8 79 ± 9 <0.001 
Mean arterial pressure (mmHg) 103 ± 6 100 ± 7 <0.001 
Pulse pressure (mmHg) 65 ± 9 63 ± 9 <0.001 
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Table 4 
Differences in characteristics between Digital Medicine patients who at 90 days 
achieved blood pressure control (n=111) and did not achieve blood pressure control 
(n=45).  
 
 
 
Blood 
Pressure 
Controlled at 
90 days 
(n=111) 
Blood Pressure 
Uncontrolled at 
90 days (n=45) 
p-value 
Age (years) 67 ± 10 70 ± 10 NS 
Gender (% female) 51% 57% NS 
Body mass index (kg/m2) 30.2 ±6.1 31.9 ± 6.8 NS 
% Black 17% 30% 0.09 
% Diabetic 21% 46% 0.002 
Baseline systolic pressure (mmHg) 143 ±19 154 ±13 0.001 
Baseline diastolic pressure (mmHg) 81 ± 12 82 ± 10 NS 
90-day systolic pressure (mmHg) 127 ± 8 148 ± 7 <0.001 
90-day diastolic pressure (mmHg) 74 ± 8 81 ± 10 <0.001 
Creatinine (mg/dl) 1.0 ±0.4 1.2 ± 0.7 NS 
eGFR (ml/min/1.73m2) 57.5 ± 7.9 54.2 ± 11.0 NS 
% Obese 48% 59% NS 
Physically inactive (%) 75% 77% NS 
Lives alone (%) 15% 25% 0.12 
Depression (%) 11% 32% 0.002 
Poor health literacy (%) 5% 11% 0.12 
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Medication affordability issue (%) 6% 27% <0.001 
Obstructive sleep apnea screen + 
(%) 
26% 39% 0.11 
High dietary sodium intake (%) 34% 27% NS 
Low medication adherence (%) 15% 18% NS 
Low patient activation (%) 14% 16% NS 
Poor technology skills (%) 15% 34% 0.07 
Number of entry antihypertensive 
meds 
3.2 ± 1.5 4.4 ± 1.5 <0.001 
Blood pressure submissions/week 4.3 ± 3.8 4.3 + 3.2 NS 
Low health capability (%) 32% 55% <0.01 
Health capability score 0.39 ± 0.64 0.80 ± 0.82 0.002 
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Table 5 
Health capability score and 90-Day blood pressure control in Digital Medicine 
patients. 
 
 
Health Capability score 0 1 2+  
Blood Pressure Controlled 79% (76) 67% (28)* 39% (7)† 
Blood Pressure 
Uncontrolled 
21% (20) 33% (14) 61% (11) 
* OR=0.58 (CI 0.26 – 1.3; p=0.20)      † OR=0.17 (CI 0.06 – 0.50; p=0.001) 
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Clinical Significance 
 
• Hypertension can be safely and effectively managed using a digital health platform, achieving 
better blood pressure control than traditional office-based care 
• A digital platform for managing chronic disease is well accepted by patients and enhances 
patient engagement 
 
• Factors in the patient domain including health literacy, patient activation, social isolation and 
medication affordability play a significant role in chronic disease control and should be 
considered in population health management strategies 
